Radiant Sage Partners with Major Pharmaceutical Company
News Jan 09, 2012
The significantly enriched tool will be a fully validated and supported open source solution that will enable clinical trial sponsors and their partners to submit and share images through one common user interface.
"During a clinical trial, image transfer between the sponsor and their partners can be a very cumbersome process as images and related data are captured and organized differently by the various acquirers. Our pharmaceutical partner realized the need for one open source solution that could be used by all of its partners which would enable images to be transmitted in a standardized format and organized to meet the specific clinical trial requirements," said Venkatesan Thangaraj, CEO and president at Radiant Sage. "Together, our objective is to turn the ImageLink tool into a valuable, validated and fully supported solution that will help drive its adoption rate rapidly among the potential end-user organizations."
Through the partnership, the two organizations are integrating this tool as a plug-in to Radiant Sage's Corelab-in-a-Box™ and Image Collaborative Portal solutions. Radiant Sage will ensure the tool is authenticated by the necessary industry organizations, regularly update and maintain the solution, and serve as the technology provider to support end users. The open source model will also enable end users to further customize the application as desired and submit their changes back to the open source repository for others to share.
"We believe our current pharmaceutical partner will benefit immensely from having one common interface to use for its multiple vendors and from the adaptability and ease of integration of this open source tool," added Thangaraj. "Our longer-term vision is making this tool an industry standard so that all sponsors and vendors will have one, customizable tool for transmitting clinical image data organized in the required manner."
The enhanced version of ImageLink will be available to the market in early 2012.